The Relationship Between Adherence and Total Spending Among Medicare Beneficiaries With Type 2 DiabetesApril 19th 2017
This study describes a widespread variation in medication adherence, pharmacy cost sharing, and medical spending. Increased cost sharing may decrease adherence and increase total diabetes spending.
Representativeness of Dipeptidyl-Peptidase-4 Inhibitor Cardiovascular Outcomes TrialsSeptember 20th 2016
Given the growing prevalence of type 2 diabetes (T2D) and its contribution to cardiovascular disease, cardiovascular outcomes trials should aim to be more representative of the average patient with T2D.